(PharmaNewsWire.Com, April 28, 2020 ) The growth in this market is majorly attributed to factors such as rising animal healthcare expenditure, rising pet adoption, growing demand for animal-derived food products, increasing number of veterinary practitioners and their growing income levels in developed regions, increasing number of animal research activities along with growing research grants, and rising awareness about zoonotic diseases.
The global animal parasiticides market is segmented based on product type, animal type, and geography. Based on product type, the market is segmented into endoparasiticides, ectoparasiticides, and endectocides. The ectoparasiticides market is further segmented into pour-ons and spot-ons, sprays, dips, oral tablets, collars, and other ectoparasiticides.
Based on animal type, the market is segmented into companion animals and food-producing animals. The food-producing animals segment is further segmented into cattle, pigs, sheep and goats, poultry, and other food-producing animals. Similarly, on the basis of geography, the animal parasiticides market is segmented into Europe, North-America, Asia-Pacific, and Rest of the World.
In 2014, ectoparasiticides accounted for the largest share of the global animal parasiticides market and this segment is expected to witness the highest growth over the next five years. The high growth in this segment can be attributed to the advantages offered by ectoparasiticides over other parasiticide formulations.
Europe is the largest regional segment for animal parasiticides owing to the well-established animal healthcare market and growing R&D activities in this region. However, the market in the Asia-Pacific region is expected to grow at the highest CAGR, owing to rising pet adoption and increasing demand for animal-derived food products in India and China.
The market players, namely, Sanofi (France), Bayer AG (Germany), and Zoetis, Inc. (U.S.) together accounted for the largest share of the animal parasiticides market and will continue to dominate the market between 2015 and 2020.
Some of the major players operating in this market are Sanofi (France), Ceva Sante Animale (France), Virbac (France), Vetoquinol S.A. (France), Eli Lilly and Company (U.S.), Zoetis, Inc. (U.S.), Merck and Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), and Perrigo Company Plc (Ireland).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
